Asia-Pacific Acute Myeloid Leukemia Diagnostics Market to 2032
Overview
The Asia-Pacific Acute Myeloid Leukemia Diagnostics Market is expected to reach a 1,761.80 USD Million by 2032 and is projected to grow at a CAGR of 18.96% from 2025 to 2032.
Revenue, 2024 (USD Million)
664.54
Forecast, 2032 (USD Million)
1,761.80
CAGR, 2024 - 2032
18.96%
Report Coverage
Asia-Pacific
Asia-Pacific Acute Myeloid Leukemia Diagnostics Market 2018-2032 USD Million
Asia-Pacific Acute Myeloid Leukemia Diagnostics Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 664.54 USD Million
- Projected Market Size (2032): 1,761.80 USD Million
- CAGR (2025-2032): 18.96%
Key Findings of Asia-Pacific Acute Myeloid Leukemia Diagnostics Market
- The Asia-Pacific Acute Myeloid Leukemia Diagnostics Market was valued at 664.54 USD Million in 2024.
- The Asia-Pacific Acute Myeloid Leukemia Diagnostics Market is likely to grow at a CAGR of 18.96% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment 65 and Above in Age Group Segment accounted for the largest share of the market with a revenue of 520.84 USD Million
- The fastest growing segment Myeloblastic (M0) in Cancer Segment grew Fastest with a CAGR of 25.49% during the forecast period from 2024 to 2032.
Asia-Pacific Acute Myeloid Leukemia Diagnostics Market Scope
Asia-Pacific Acute Myeloid Leukemia Diagnostics Market Segmentation & Scope
Cancer
- Megakaryocytic (M7)
- Erythroleukemia (M6)
- Monocytic (M5)
- Myelomonocytic (M4)
- Promyelocytic (M3)
- Myeloblastic (M2)
- Myeloblastic (M1)
- Myeloblastic (M0)
Age Group
- 21-29
- Below 21
- 30-65
- 65 and Above
Distribution Channel
- Retail Sales
- Direct Tender
End User
- Others
- Cancer Research Institutes
- Diagnostic Imaging Centers
- Independent Diagnostic Laboratories
- Associated Labs
- Hospitals
Gender
- Female
- Male
Product
- Consumables & Accessories
- Instruments
Test
- Others
- Immunophenotyping
- Biomarker Test
- Genetic Tests
- Bone Marrow Tests
- Imaging Test
- Blood Test
Asia-Pacific Acute Myeloid Leukemia Diagnostics Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2021 |
| Unit | Revenue in USD Million |
| Market Value in 2024 | 664.54 USD Million |
| Market Value in 2032 | 1,761.80 USD Million |
| CAGR (2025-2032) | 18.96% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Cancer,Age Group,Distribution Channel,End User,Gender,Product,Test |
Regional Insights:
-
Leading Market (2024-2032): Asia-Pacific, leading in terms of revenue 664.54 USD Million in 2024
- Key Country: China, leading in terms of revenue with value of 233.81 USD Million in 2024.
Segments and Scope
-
Asia-Pacific Acute Myeloid Leukemia Diagnostics Market to 2032, By Cancer
- Myeloblastic (M0) is the largest segment in Asia-Pacific Acute Myeloid Leukemia Diagnostics Market to 2032 with a revenue of 195.43 USD Million in the year 2024.
- Myeloblastic (M0) is the Fastest growing segment in Asia-Pacific Acute Myeloid Leukemia Diagnostics Market to 2032 with a Growth rate of 25.49 % in forecast period 2025-2032.
-
Asia-Pacific Acute Myeloid Leukemia Diagnostics Market to 2032, By Age Group
- 65 and Above is the largest segment in Asia-Pacific Acute Myeloid Leukemia Diagnostics Market to 2032 with a revenue of 520.84 USD Million in the year 2024.
- 65 and Above is the Fastest growing segment in Asia-Pacific Acute Myeloid Leukemia Diagnostics Market to 2032 with a Growth rate of 19.70 % in forecast period 2025-2032.
-
Asia-Pacific Acute Myeloid Leukemia Diagnostics Market to 2032, By Distribution Channel
- Direct Tender is the largest segment in Asia-Pacific Acute Myeloid Leukemia Diagnostics Market to 2032 with a revenue of 449.94 USD Million in the year 2024.
- Direct Tender is the Fastest growing segment in Asia-Pacific Acute Myeloid Leukemia Diagnostics Market to 2032 with a Growth rate of 20.83 % in forecast period 2025-2032.
-
Asia-Pacific Acute Myeloid Leukemia Diagnostics Market to 2032, By End User
- Hospitals is the largest segment in Asia-Pacific Acute Myeloid Leukemia Diagnostics Market to 2032 with a revenue of 227.08 USD Million in the year 2024.
- Hospitals is the Fastest growing segment in Asia-Pacific Acute Myeloid Leukemia Diagnostics Market to 2032 with a Growth rate of 23.90 % in forecast period 2025-2032.
-
Asia-Pacific Acute Myeloid Leukemia Diagnostics Market to 2032, By Gender
- Male is the largest segment in Asia-Pacific Acute Myeloid Leukemia Diagnostics Market to 2032 with a revenue of 394.89 USD Million in the year 2024.
- Male is the Fastest growing segment in Asia-Pacific Acute Myeloid Leukemia Diagnostics Market to 2032 with a Growth rate of 20.91 % in forecast period 2025-2032.
-
Asia-Pacific Acute Myeloid Leukemia Diagnostics Market to 2032, By Product
- Instruments is the largest segment in Asia-Pacific Acute Myeloid Leukemia Diagnostics Market to 2032 with a revenue of 452.11 USD Million in the year 2024.
- Instruments is the Fastest growing segment in Asia-Pacific Acute Myeloid Leukemia Diagnostics Market to 2032 with a Growth rate of 19.94 % in forecast period 2025-2032.
-
Asia-Pacific Acute Myeloid Leukemia Diagnostics Market to 2032, By Test
- Blood Test is the largest segment in Asia-Pacific Acute Myeloid Leukemia Diagnostics Market to 2032 with a revenue of 203.93 USD Million in the year 2024.
- Blood Test is the Fastest growing segment in Asia-Pacific Acute Myeloid Leukemia Diagnostics Market to 2032 with a Growth rate of 23.78 % in forecast period 2025-2032.
Asia-Pacific Acute Myeloid Leukemia Diagnostics Market Company Share Analysis
| Company Name |
|
||
| Myriad Genetics, Inc. | |||
| Sysmex Corporation | |||
| QIAGEN | |||
| BIOMÉRIEUX | |||
| CANON MEDICAL SYSTEMS CORPORATION | |||
Asia-Pacific Acute Myeloid Leukemia Diagnostics Market Geographical Sales Distribution, 2018-2032 USD Million
Asia-Pacific Acute Myeloid Leukemia Diagnostics Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The Asia-Pacific Acute Myeloid Leukemia Diagnostics Market is segmented based on Segmentation Cancer,Age Group,Distribution Channel,End User,Gender,Product,Test.
Asia-Pacific Acute Myeloid Leukemia Diagnostics Market was valued at USD 664.54(Revenue in USD Million) in 2021.
Asia-Pacific Acute Myeloid Leukemia Diagnostics Market is projected to grow at a CAGR of 18.96% during the forecast period of 2024 to 2032.
The 65 and Above segment is expected to dominate the Asia-Pacific Acute Myeloid Leukemia Diagnostics Market, holding a largest market share of 520.84 USD Million in 2024
Asia-Pacific Acute Myeloid Leukemia Diagnostics Market Scope
Asia-Pacific Acute Myeloid Leukemia Diagnostics Market Segmentation & Scope
Cancer
- Megakaryocytic (M7)
- Erythroleukemia (M6)
- Monocytic (M5)
- Myelomonocytic (M4)
- Promyelocytic (M3)
- Myeloblastic (M2)
- Myeloblastic (M1)
- Myeloblastic (M0)
Age Group
- 21-29
- Below 21
- 30-65
- 65 and Above
Distribution Channel
- Retail Sales
- Direct Tender
End User
- Others
- Cancer Research Institutes
- Diagnostic Imaging Centers
- Independent Diagnostic Laboratories
- Associated Labs
- Hospitals
Gender
- Female
- Male
Product
- Consumables & Accessories
- Instruments
Test
- Others
- Immunophenotyping
- Biomarker Test
- Genetic Tests
- Bone Marrow Tests
- Imaging Test
- Blood Test
Frequently Asked Questions
The Asia-Pacific Acute Myeloid Leukemia Diagnostics Market is segmented based on Segmentation Cancer,Age Group,Distribution Channel,End User,Gender,Product,Test.
Asia-Pacific Acute Myeloid Leukemia Diagnostics Market was valued at USD 664.54(Revenue in USD Million) in 2021.
Asia-Pacific Acute Myeloid Leukemia Diagnostics Market is projected to grow at a CAGR of 18.96% during the forecast period of 2024 to 2032.
The estimated market value of the Asia-Pacific Acute Myeloid Leukemia Diagnostics Market for final year is USD 1,761.80 (USD Million).
Asia-Pacific Acute Myeloid Leukemia Diagnostics Market Company Profiling
Frequently Asked Questions
The Asia-Pacific Acute Myeloid Leukemia Diagnostics Market is segmented based on Segmentation Cancer,Age Group,Distribution Channel,End User,Gender,Product,Test.
Asia-Pacific Acute Myeloid Leukemia Diagnostics Market was valued at USD 664.54(Revenue in USD Million) in 2021.
Asia-Pacific Acute Myeloid Leukemia Diagnostics Market is projected to grow at a CAGR of 18.96% during the forecast period of 2024 to 2032.
The estimated market value of the Asia-Pacific Acute Myeloid Leukemia Diagnostics Market for final year is USD 1,761.80 (USD Million).
CHOOSE LICENCE TYPE
- 4200.00
- 3500.00
- 2000.00
- 5500.00
- 8500.00
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.